Loading
Matthew Inada-Kim

Matthew Inada-Kim

National Clinical Director for Infection, Antimicrobial Resistance & Deterioration, NHSE&I
Matt is consultant in Acute Medicine at Hampshire Hospitals, National Clinical Director for Infection management and Deterioration, National Clinical Lead for COVID oximetry@home, Chair of the COVID pathways group at NHS England/Improvement and Clinical Director for Safety/digital at Wessex AHSN. He sits on the national COVID clinical reference group for primary care, care homes and hospitals. To this end he has developed and co lead on the virtual ward model, and the COVID management guidance/policy in all settings and evidence for the role of oximetry for all patient groups. He has worked to improve processes in the recognition, escalation, communication and response to the deteriorating patient. To this end, he has worked to standardise the country to using NEWS2 as a single language of sickness & communication between healthcare professionals across the whole patient pathway. He is also improving the measurement and definitions of sepsis and infection to assist epidemiology, research and policy. He is working across the country to develop interoperable digital systems and databases that will enable machine learning and AI systems at scale alongside existing clinical pathways.
Sessions